Waltham, MA, United States of America

Susan Cantin

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Cantin. Retrieved from https://idiyas.com/inventor/susan-cantin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susan Cantin: Innovator in Cancer Treatment

Introduction

Susan Cantin is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of cancer treatment through her innovative work. With a focus on developing effective therapies, her research has the potential to impact many lives.

Latest Patents

Susan holds a patent for a groundbreaking invention titled "Combination Therapy for Treating Cancer." This patent represents her commitment to advancing medical science and improving treatment options for cancer patients. She has 1 patent to her name, showcasing her dedication to innovation in healthcare.

Career Highlights

Susan is currently employed at AstraZeneca, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to collaborate with other experts in the field and contribute to the development of new therapies. Her work is instrumental in pushing the boundaries of cancer treatment.

Collaborations

Throughout her career, Susan has worked alongside talented colleagues, including Aatman Doshi and Alwin Schuller. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

Susan Cantin is a remarkable inventor whose work in cancer treatment exemplifies the power of innovation in medicine. Her contributions are paving the way for new therapeutic approaches that can benefit countless patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…